comparemela.com
  1. Home
  2. Live Updates
  3. Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies : comparemela.com

Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies

Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston ,Massachusetts ,United States ,Marcio Souza ,Ian Stone ,Ionis Pharmaceutics Inc ,Facebook ,European Medical Agency ,Rogcon Inc ,Linkedin ,Praxis Precision Medicines Inc ,Nasdaq ,European Medicines Agency ,Canale Communications ,Function Developmental ,Precision Medicines ,Priority Medicines ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Ionis Pharmaceutics ,Praxis Precision Medicines ,Media Contact ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.